Shelly L Carter
Overview
Explore the profile of Shelly L Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Burik J, Carter S, Freifeld A, High K, Godder K, Papanicolaou G, et al.
Biol Blood Marrow Transplant
. 2007 Nov;
13(12):1487-98.
PMID: 18022579
Serious infections are a major obstacle limiting the usefulness of unrelated donor marrow transplantation. Graft-versus-host disease (GVHD) and its therapy are associated with a high risk of opportunistic infection. In...
12.
Copelan E, Casper J, Carter S, van Burik J, Hurd D, Mendizabal A, et al.
Biol Blood Marrow Transplant
. 2007 Nov;
13(12):1469-76.
PMID: 18022577
The primary cause of death (COD) provides important information in many studies of hematopoietic stem cell transplantation (HSCT). A panel of experts critically assessed the CODs submitted by 15 transplantation...
13.
Cohen G, Carter S, Weinberg K, Masinsin B, Guinan E, Kurtzberg J, et al.
Biol Blood Marrow Transplant
. 2006 Dec;
12(12):1335-42.
PMID: 17162216
It has not been possible to determine the singular contribution of naive T lymphocytes to antigen-specific immunity after hematopoietic stem cell transplantation (HSCT), because of the confounding effects of donor-derived...
14.
Parkman R, Cohen G, Carter S, Weinberg K, Masinsin B, Guinan E, et al.
Biol Blood Marrow Transplant
. 2006 Aug;
12(9):919-27.
PMID: 16920557
Allogeneic hematopoietic stem cell transplantation (HSCT) is established therapy for selected patients with acute leukemia. After transplantation, antileukemic immune responses are believed to eliminate residual leukemia cells and decrease the...
15.
Altmaier E, Ewell M, McQuellon R, Geller N, Carter S, Henslee-Downey J, et al.
Biol Blood Marrow Transplant
. 2006 Jun;
12(6):648-55.
PMID: 16737938
The primary objective of this study was to compare health-related quality of life (HRQL) in adult patients undergoing either ex vivo T cell-depleted bone marrow transplantation or conventional marrow transplantation....
16.
Martin P, Carter S, Kernan N, Sahdev I, Wall D, Pietryga D, et al.
Biol Blood Marrow Transplant
. 2006 Jan;
12(2):184-94.
PMID: 16443516
The Cord Blood Transplantation Study (COBLT), sponsored by the National Heart, Lung, and Blood Institute, is a phase II multicenter study designed to evaluate the use of cord blood in...
17.
Wagner J, Thompson J, Carter S, Kernan N
Lancet
. 2005 Aug;
366(9487):733-41.
PMID: 16125590
Background: Graft-versus-host disease (GVHD) reduces the efficacy of unrelated donor bone marrow transplantation in patients with lymphohaemopoietic malignancy. A multi-centre, randomised trial was undertaken to determine the effects of ex-vivo...
18.
Pavletic S, Carter S, Kernan N, Henslee-Downey J, Mendizabal A, Papadopoulos E, et al.
Blood
. 2005 Jul;
106(9):3308-13.
PMID: 16046530
Donor-derived T cells have been proposed to play a role in pathogenesis of chronic graft-versus-host disease (cGVHD). The impact of ex vivo T-cell depletion (TCD) on cGVHD was analyzed in...
19.
Wall D, Carter S, Kernan N, Kapoor N, Kamani N, Brochstein J, et al.
Biol Blood Marrow Transplant
. 2005 Jul;
11(8):637-46.
PMID: 16041314
A non-total body irradiation-containing preparative regimen was studied in young children (<4 years old) undergoing unrelated donor cord blood transplantation as part of the Cord Blood Transplantation trial for the...
20.
Cairo M, Wagner E, Fraser J, Cohen G, van de Ven C, Carter S, et al.
Transfusion
. 2005 Jun;
45(6):856-66.
PMID: 15934982
Background: The Cord Blood Transplantation (COBLT) Study banking program was initiated in 1996. The study goals were to develop standard operating procedures for cord blood (CB) donor recruitment and banking...